(MRM) Medirom Healthcare - Ratings and Ratios
Exchange: NASDAQ • Country: Japan • Currency: USD • Type: Common Stock • ISIN: US58510H1032
MRM: Massage, Therapy, Fitness, Healthcare, Beauty, Guidance, Wellness
MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) operates as a holistic health services provider in Japan, targeting diverse consumer needs across three core segments: Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty. The Relaxation Salon segment, under Re.Ra.Ku and Ruam Ruam, offers therapies like finger-pressure bodywork and posture alignment, appealing to busy professionals seeking stress relief. The Digital Preventative Healthcare segment leverages technology, such as the Lav app and MOTHER Bracelet, to provide telehealth services, attracting health-conscious individuals. The Luxury Beauty segment, under ZACC, caters to high-end clients with premium salon services.
The companys strategic focus includes expansion through franchising and continuous training at Re.Ra.Ku College, enhancing customer service and operational efficiency. Their services are culturally tailored to Japans wellness trends, integrating traditional therapies with modern technology. This blend reflects a commitment to innovation and customer-centric care.
From a technical standpoint, MRMs stock shows a downtrend, trading below its SMA 20 and SMA 50 at $0.64, with low volatility indicated by an ATR of 0.07. Fundamentally, the high P/B ratio of 13.24 and a RoE of 323 suggest efficient equity use, though the lack of profitability is concerning. The 3-month forecast predicts continued decline due to bearish technicals and high valuation, with potential interest from growth investors despite profitability concerns.
Additional Sources for MRM Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
MRM Stock Overview
| Market Cap in USD | 6m |
| Sector | Consumer Cyclical |
| Industry | Personal Services |
| GiC Sub-Industry | Health Care Services |
| IPO / Inception | 2020-12-29 |
MRM Stock Ratings
| Growth Rating | -86.0 |
| Fundamental | 23.8 |
| Dividend Rating | 0.0 |
| Rel. Strength | -86.7 |
| Analysts | - |
| Fair Price Momentum | 0.51 USD |
| Fair Price DCF | - |
MRM Dividends
No Dividends PaidMRM Growth Ratios
| Growth Correlation 3m | -58.2% |
| Growth Correlation 12m | -93.1% |
| Growth Correlation 5y | -90.7% |
| CAGR 5y | -49.65% |
| CAGR/Max DD 5y | -0.51 |
| Sharpe Ratio 12m | -1.17 |
| Alpha | -94.78 |
| Beta | 1.489 |
| Volatility | 318.83% |
| Current Volume | 20.6k |
| Average Volume 20d | 132.1k |
As of April 19, 2025, the stock is trading at USD 0.79 with a total of 20,630 shares traded.
Over the past week, the price has changed by -25.38%, over one month by +51.50%, over three months by -15.86% and over the past year by -86.82%.
Neither. Based on ValueRay Fundamental Analyses, Medirom Healthcare is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 23.80 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MRM as of April 2025 is 0.51. This means that MRM is currently overvalued and has a potential downside of -35.44%.
Medirom Healthcare has no consensus analysts rating.
According to ValueRays Forecast Model, MRM Medirom Healthcare will be worth about 0.6 in April 2026. The stock is currently trading at 0.79. This means that the stock has a potential downside of -26.58%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 5.3 | 568.4% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 0.6 | -26.6% |